Detalles de la búsqueda
1.
Angiotensin-converting enzyme inhibitors improve coronary flow reserve in dilated cardiomyopathy by a bradykinin-mediated, nitric oxide-dependent mechanism.
Circulation
; 105(23): 2785-90, 2002 Jun 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-12057995
2.
Recombinant glucagon-like peptide-1 increases myocardial glucose uptake and improves left ventricular performance in conscious dogs with pacing-induced dilated cardiomyopathy.
Circulation
; 110(8): 955-61, 2004 Aug 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-15313949
3.
Catecholamine stimulation is associated with impaired myocardial O(2) utilization in heart failure.
Cardiovasc Res
; 53(2): 392-404, 2002 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-11827690
4.
Catecholamines restore myocardial contractility in dilated cardiomyopathy at the expense of increased coronary blood flow and myocardial oxygen consumption (MvO2 cost of catecholamines in heart failure).
Eur J Heart Fail
; 6(4): 409-19, 2004 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-15182765
5.
Glucagon-like peptide-1 limits myocardial stunning following brief coronary occlusion and reperfusion in conscious canines.
J Pharmacol Exp Ther
; 312(1): 303-8, 2005 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-15356213
6.
Coronary blood flow responses are impaired independent of NO and endothelial function in conscious dogs with dilated cardiomyopathy.
J Card Fail
; 11(4): 313-21, 2005 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-15880342
Resultados
1 -
6
de 6
1
Próxima >
>>